Other pharmacological effects

Pharmacological Evaluation of Metabolic System Diseases (Obesity/Diabetes and Complications, Hyperglycemic Clamp Study, Insulin Resistance, Hyperuricemia, Obesity, etc.) Inflammatory and Immune System Diseases Efficacy evaluation of drug candidates in pediatric disease models (chronic visceral hypersensitivity model in young rats, precocious puberty, etc.) and respiratory disease models (pulmonary fibrosis). Urinary System Diseases (Drug- and Surgery-Induced Renal Injury, Renal Insufficiency) Liver diseases (such as hepatic ascites, liver cirrhosis, liver fibrosis, alcoholic liver disease, etc.), skin and ophthalmological disorders, and others.

Other pharmacological effects

Pharmacological Evaluation of Metabolic System Diseases (Obesity/Diabetes and Complications, Hyperglycemic Clamp Study, Insulin Resistance, Hyperuricemia, Obesity, etc.) Inflammatory and Immune System Diseases

Efficacy evaluation of drug candidates in pediatric disease models (chronic visceral hypersensitivity model in young rats, precocious puberty, etc.) and respiratory disease models (pulmonary fibrosis).

Urinary System Diseases (Drug- and Surgery-Induced Renal Injury, Renal Insufficiency)

Liver diseases (such as hepatic ascites, liver cirrhosis, liver fibrosis, alcoholic liver disease, etc.), skin and ophthalmological disorders, and more.